452 related articles for article (PubMed ID: 17577801)
1. Bupropion and cognitive-behavioral treatment for depression in smoking cessation.
Brown RA; Niaura R; Lloyd-Richardson EE; Strong DR; Kahler CW; Abrantes AM; Abrams D; Miller IW
Nicotine Tob Res; 2007 Jul; 9(7):721-30. PubMed ID: 17577801
[TBL] [Abstract][Full Text] [Related]
2. Smoking cessation interventions for smokers with current or past depression.
van der Meer RM; Willemsen MC; Smit F; Cuijpers P
Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
Evins AE; Culhane MA; Alpert JE; Pava J; Liese BS; Farabaugh A; Fava M
J Clin Psychopharmacol; 2008 Dec; 28(6):660-6. PubMed ID: 19011435
[TBL] [Abstract][Full Text] [Related]
4. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.
Hall SM; Reus VI; Muñoz RF; Sees KL; Humfleet G; Hartz DT; Frederick S; Triffleman E
Arch Gen Psychiatry; 1998 Aug; 55(8):683-90. PubMed ID: 9707377
[TBL] [Abstract][Full Text] [Related]
5. A bupropion smoking cessation clinical trial for cancer patients.
Schnoll RA; Martinez E; Tatum KL; Weber DM; Kuzla N; Glass M; Ridge JA; Langer C; Miyamoto C; Wileyto EP; Leone F
Cancer Causes Control; 2010 Jun; 21(6):811-20. PubMed ID: 20087643
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.
Cox LS; Patten CA; Niaura RS; Decker PA; Rigotti N; Sachs DP; Buist AS; Hurt RD
J Gen Intern Med; 2004 Aug; 19(8):828-34. PubMed ID: 15242467
[TBL] [Abstract][Full Text] [Related]
7. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
[TBL] [Abstract][Full Text] [Related]
8. Bupropion and cognitive-behavioral therapy for smoking cessation in women.
Schmitz JM; Stotts AL; Mooney ME; Delaune KA; Moeller GF
Nicotine Tob Res; 2007 Jun; 9(6):699-709. PubMed ID: 17558827
[TBL] [Abstract][Full Text] [Related]
9. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
10. A placebo controlled trial of bupropion for smoking cessation in schizophrenia.
George TP; Vessicchio JC; Termine A; Bregartner TA; Feingold A; Rounsaville BJ; Kosten TR
Biol Psychiatry; 2002 Jul; 52(1):53-61. PubMed ID: 12079730
[TBL] [Abstract][Full Text] [Related]
11. Cognitive-behavioral treatment with behavioral activation for smokers with depressive symptomatology: study protocol of a randomized controlled trial.
Becoña E; Martínez-Vispo C; Senra C; López-Durán A; Rodríguez-Cano R; Fernández Del Río E
BMC Psychiatry; 2017 Apr; 17(1):134. PubMed ID: 28390417
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism.
Hayford KE; Patten CA; Rummans TA; Schroeder DR; Offord KP; Croghan IT; Glover ED; Sachs DP; Hurt RD
Br J Psychiatry; 1999 Feb; 174():173-8. PubMed ID: 10211174
[TBL] [Abstract][Full Text] [Related]
13. Bupropion for smoking cessation: a randomized trial.
Simon JA; Duncan C; Carmody TP; Hudes ES
Arch Intern Med; 2004 Sep; 164(16):1797-803. PubMed ID: 15364675
[TBL] [Abstract][Full Text] [Related]
14. Interventions for smoking cessation and reduction in individuals with schizophrenia.
Tsoi DT; Porwal M; Webster AC
Cochrane Database Syst Rev; 2010 Jun; (6):CD007253. PubMed ID: 20556777
[TBL] [Abstract][Full Text] [Related]
15. Effect of bupropion on depression symptoms in a smoking cessation clinical trial.
Lerman C; Niaura R; Collins BN; Wileyto P; Audrain-McGovern J; Pinto A; Hawk L; Epstein LH
Psychol Addict Behav; 2004 Dec; 18(4):362-6. PubMed ID: 15631608
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
[TBL] [Abstract][Full Text] [Related]
17. Psychological intervention and antidepressant treatment in smoking cessation.
Hall SM; Humfleet GL; Reus VI; Muñoz RF; Hartz DT; Maude-Griffin R
Arch Gen Psychiatry; 2002 Oct; 59(10):930-6. PubMed ID: 12365880
[TBL] [Abstract][Full Text] [Related]
18. Development of depression during placebo-controlled trials of bupropion for smoking cessation: case reports.
Patten CA; Rummans TA; Croghan IT; Hurt RD; Hays JT
J Clin Psychiatry; 1999 Jul; 60(7):436-41. PubMed ID: 10453796
[TBL] [Abstract][Full Text] [Related]
19. Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial.
Mooney ME; Schmitz JM; Allen S; Grabowski J; Pentel P; Oliver A; Hatsukami DK
Clin Pharmacol Ther; 2016 Oct; 100(4):344-52. PubMed ID: 27213949
[TBL] [Abstract][Full Text] [Related]
20. The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial.
Cinciripini PM; Kypriotakis G; Green C; Lawrence D; Anthenelli RM; Minnix J; Blalock JA; Beneventi D; Morris C; Karam-Hage M
Depress Anxiety; 2022 May; 39(5):429-440. PubMed ID: 35535436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
